These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23319227)

  • 1. Botulinum toxin in the treatment of post-traumatic headache - case study.
    Lippert-Grüner M
    Neurol Neurochir Pol; 2012; 46(6):591-4. PubMed ID: 23319227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of botulinum toxins for chronic headaches: a focused review.
    Loder E; Biondi D
    Clin J Pain; 2002; 18(6 Suppl):S169-76. PubMed ID: 12569965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
    Zirovich MD; Pangarkar SS; Manh C; Chen L; Vangala S; Elashoff DA; Izuchukwu IS
    Mil Med; 2021 May; 186(5-6):493-499. PubMed ID: 33241323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence based medicine on the use of botulinum toxin for headache disorders.
    Schulte-Mattler WJ; Leinisch E
    J Neural Transm (Vienna); 2008; 115(4):647-51. PubMed ID: 17994180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of botulinum toxin A treatment for tension-type or cervicogenic headache: a systematic review and meta-analysis of randomized, placebo-controlled trials.
    Roland SB; Pripp AH; Msomphora MR; Kvarstein G
    Scand J Pain; 2021 Oct; 21(4):635-652. PubMed ID: 34090319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of botulinum toxin for chronic tension-type headache prophylaxis: A systematic review and meta-analysis.
    Dhanasekara CS; Payberah D; Chyu JY; Shen CL; Kahathuduwa CN
    Cephalalgia; 2023 Mar; 43(3):3331024221150231. PubMed ID: 36786349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of botulinum toxin in the treatment of headaches.
    Mauskop A
    Curr Pain Headache Rep; 2002 Aug; 6(4):320-3. PubMed ID: 12095468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botox treatment for migraine and chronic daily headache in adolescents.
    Chan VW; McCabe EJ; MacGregor DL
    J Neurosci Nurs; 2009 Oct; 41(5):235-43. PubMed ID: 19835236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A and headache treatment.
    Gady J; Ferneini EM
    Conn Med; 2013 Mar; 77(3):165-6. PubMed ID: 23589955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K; Oas KH; Mack KJ; Garza I
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience.
    Farinelli I; Coloprisco G; De Filippis S; Martelletti P
    J Headache Pain; 2006 Dec; 7(6):407-12. PubMed ID: 17149565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional Treatment for Post-traumatic Headache.
    Conidi FX
    Curr Pain Headache Rep; 2016 Jun; 20(6):40. PubMed ID: 27130542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL; Kuriyama A; Hayashino Y
    JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.